Home
January 2010 February 2010 March 2010
Su Mo Tu We Th Fr Sa
Week 5 1 2 3 4 5 6
Week 6 7 8 9 10 11 12 13
Week 7 14 15 16 17 18 19 20
Week 8 21 22 23 24 25 26 27
Week 9 28
Reach urologists

Prostate Biopsy Patterns in the CaPSURE Database: Evolution with Time and Impact on Outcome after Prostatectomy Show Comments PDF Print E-mail
  
Thursday, 20 December 2007

BERKELEY, CA (UroToday.com) - According to a report in the early view section of the Journal of Urology by Dr. Shah and CaPSURE investigators, increasing number of prostate biopsy cores may have contributed indirectly to improved outcomes after radical prostatectomy in the last decade.

CaPSURE is a longitudinal, observational registry of men with biopsy proven prostate cancer. Between 1995 and 2004, 6,450 men from this registry were included in this analysis of patterns of prostate biopsy and outcome following radical prostatectomy (RP). The mean number of biopsy cores removed was 9.1 and the mean number of positive biopsy cores was 2.9. The mean percent of cores involved with cancer was 33.3%.

The mean number of cores removed increased from 6.9 in 1995 to 10.2 in 2004. However, the number of positive biopsy cores remained unchanged from 2.9 in 1995 to 3.2 in 2004 (not statistically significant). At a median postoperative followup of 2.6 years, 214 of the 1,757 men undergoing RP (12%) had a recurrence; identified as a biochemical recurrence in 162 (76%) and administration of a secondary therapy in 52 (24%). In the proportional hazards model, none of the interactions of biopsy parameter x diagnosis proved to be statistically significant. Repeat analysis without these terms indicated that the number of cores removed did not have a direct effect on recurrence free survival. The number and percent of positive cores predicted disease recurrence after RP. The authors’ postulate the increase in the number of cores removed may have led to a biopsy core induced downward migration in risk and consequently an improvement in recurrence free survival after RP over the last decade.

Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV, CaPSURE Investigators

J Urol; 179(1):136-140, January 2008
DOI: 10.1016/j.juro.2007.08.126

PubMed Abstract
PMID: 17997437

UroToday.com Prostate Cancer Section

Written by Christopher P. Evans, MD, a Contributing Editor with UroToday.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 

Bookmark and Share
< Prev   Next >

Member's Section

Login

Sign Up

Quick Search

Meet the Expert


All Experts



Featured Conference

Media and Publisher

Advertising Rates

Working with Industry

Case Studies
Sponsorship Opportunities

Prostate Cancer
Sponsored by